Business travel can combine long journeys, unfamiliar health risks, repeated exposure, disrupted sleep, and demanding work schedules. Available data from the CDC, WHO, GeoSentinel, occupational-health studies, BCD, and GBTA shows that preparation and employer support are central parts of a safer travel program.
Table of contents
- The scale and profile of business travel
- What illness data shows
- Pre-travel preparation and cumulative risk
- Long journeys and blood-clot risk
- Sleep, stress, and mental health
- Workplace wellbeing and travel policy
The scale and profile of business travel
The CDC estimated that 4.8 million U.S. residents traveled overseas for business in 2017. That figure describes U.S. outbound business travel in one year, rather than the total number of business trips worldwide. The CDC also emphasizes that health planning should reflect the traveler, destination, and trip circumstances.
GeoSentinel provides a clinical view of business travelers who became ill or sought care. Its analysis covered 12,203 business travelers and 14,045 eligible diagnoses recorded from 1997 through 2014 across 64 travel and tropical-medicine clinics in 29 countries. The cohort was not a census of every business traveler; it represents people captured by participating clinical sites.
The profile was predominantly adult and international. Ninety-seven percent were aged 20 to 64, 74% were reported from Western Europe or North America, and two-thirds were male. Eighty-six percent were outpatients, while 45% reported a pre-travel healthcare encounter. Exposure regions included sub-Saharan Africa at 37%, Southeast Asia at 15%, and South Central Asia at 14%.
The more recent CDC MMWR analysis of ill U.S. nonmigrant travelers had a median age of 37 years, with a range from under 19 to 96. In that sample, 55.7% were female, 75.3% were born in the United States, and 89.4% were U.S. citizens. Outpatient care accounted for 90.6% of encounters. These figures describe a clinical sample of ill travelers, not the health profile of all people who travel for work.
What illness data shows
In the GeoSentinel business-traveler cohort, the most frequent diagnoses were malaria at 9%, acute unspecified diarrhea at 8%, viral syndrome at 6%, acute bacterial diarrhea at 5%, and chronic diarrhea at 4%. Species was reported for 973 patients, or 90% of the malaria patients. Among business travelers with malaria chemoprophylaxis information, 92% took none or incomplete courses.
The CDC MMWR analysis found that 43.2% of 11,987 diagnoses among U.S. nonmigrant travelers were related to the gastrointestinal system. Within those gastrointestinal diagnoses, acute diarrhea accounted for 39.3%, irritable bowel syndrome for 9.5%, campylobacteriosis for 7.2%, giardiasis for 5.5%, and chronic diarrhea for 5.2%.
Febrile illness also had a defined pattern in that analysis. Viral syndrome represented 29.0% of febrile diagnoses, malaria 21.0%, dengue 13.7%, chikungunya 6.4%, and unspecified febrile illness 5.0%. The figures are proportions within diagnostic groups, so they should not be added to the gastrointestinal percentages.
Business was the reason for travel for 13.4% of nonmigrant travelers in the early period and 12.3% in the later period of the MMWR analysis. Tourism rose from 44.8% to 53.6%, while visiting friends and relatives changed from 22.0% to 21.4%. Missionary or humanitarian-aid travel fell from 13.1% to 6.2%.
Exposure patterns also changed. Central America was the most frequent region in both periods, at 19.2% early and 17.3% later. Sub-Saharan Africa rose from 17.7% to 25.5%, Caribbean exposure fell from 13.0% to 10.9%, and Southeast Asia rose from 10.4% to 11.2%.
Malaria patterns were particularly concentrated. Plasmodium falciparum accounted for 80.8% of malaria cases in the overall nonmigrant traveler sample. Sub-Saharan Africa was the exposure region for 88.6% of malaria cases in the early period and 95.9% in the later period. Among travelers visiting friends and relatives, 70.3% and 57.9% of malaria cases occurred in the two periods; 70.2% and 83.3% lacked pre-travel health information, and 88.3% and 100% did not take malaria chemoprophylaxis.
Pre-travel preparation and cumulative risk
The CDC advises business travelers to see a healthcare provider or travel-medicine specialist at least one month before departure. It also says a last-minute visit can still be useful when a month of lead time is impossible. WHO recommends a travel-clinic visit four to eight weeks before departure, or earlier.
WHO identifies several factors that can change health risk: the traveler’s health, trip type, and destination; changes in temperature and humidity; air pollution; safety and security; access to health and dental services; infectious-disease exposure; safe food and water; sanitation and hygiene; and the availability of facilities and equipment for disabled people. WHO also describes international travel as potentially stressful, with high stress capable of causing physical, social, and psychological problems.
The CDC Yellow Book notes that a single one- or two-week business trip to a low-risk destination might not warrant immediate vaccination. It also warns that future work trips can create cumulative exposure risk. The likelihood of an adverse health event increases with the number of trips to at-risk areas, time spent there, and lifestyle at the destination. For frequent travelers, cumulative risk matters more than assessing only the next itinerary.
Practical preparation includes carrying prescribed medication for the whole trip, including possible delays and plan changes. WHO also advises carrying health-insurance certificates and vaccination or malaria-prophylaxis records. After returning, WHO says travelers should seek medical attention if they become ill in the following weeks with fever, persistent diarrhea, vomiting, jaundice, urinary disorders, skin disease, or anogenital infection.
Long journeys and blood-clot risk
The CDC says travel lasting more than four hours by air, car, or bus can put a person at risk for blood clots, although the overall risk of travel-associated clots is generally very small. Risk depends on journey duration and other personal factors.
| CDC-identified travel clot risk factor | Relevant detail |
|---|---|
| Age | Risk increases after age 40 |
| Recent surgery or injury | Within the previous 3 months |
| Pregnancy | Includes the postpartum period up to 3 months after childbirth |
| Hormones | Estrogen-containing contraceptives and hormone-replacement therapy |
| Medical history | Previous clot, inherited clotting disorder, or family history |
| Current conditions | Active cancer or recent treatment, heart or lung disease, or diabetes |
| Mobility and circulation | Limited mobility, such as a leg cast, and varicose veins |
| Body weight | Overweight or obesity |
About half of people with deep-vein thrombosis have no symptoms. The CDC lists four common DVT symptoms: swelling, unexplained pain or tenderness, warmth, and redness or discoloration. It lists six pulmonary-embolism symptoms: difficulty breathing, a faster or irregular heartbeat, chest pain, anxiety, coughing or coughing up blood, and lightheadedness or fainting. Travelers with relevant risk factors or symptoms should use medical advice appropriate to their situation.
Sleep, stress, and mental health
Business travel health is not limited to infection and injury. A 2010 study of 12,942 U.S. employees included 2,962 international travelers and 9,980 non-travelers. International business travel was associated with lower body mass index, lower blood pressure, excess alcohol consumption, sleep deprivation, and diminished confidence in keeping up with the pace of work. These are reported associations, not proof that travel caused each outcome.
A 2011 Columbia/EHE study used medical records from 13,057 patients. Compared with light travelers, nontravelers had 1.58 times the odds of poor or fair health, while extensive travelers had 2.61 times the odds. Nontravelers had 1.33 times the odds of obesity and extensive travelers 1.92 times the odds, again compared with light travelers. Nontravelers and extensive travelers also had the highest diastolic blood-pressure levels and the lowest HDL-cholesterol levels.
A 2018 Columbia/EHE study used de-identified electronic medical-record data from a corporate wellness program. Compared with travelers working away one to six nights per month, those away 21 or more nights were 3.74 times as likely to smoke, 1.37 times as likely to report trouble sleeping, and 1.95 times as likely to be sedentary. They were also 2.04 times as likely to score above the alcohol-dependence threshold, 1.69 times as likely to score above the mild-anxiety threshold, and 2.27 times as likely to score above the mild-depression threshold.
BCD’s sleep survey found that 26% of respondents regularly slept well on business trips, 53% did so sometimes, and 21% rarely did. Lack of sleep and jet lag were major concerns for 36%, and one in five named jet lag as a major post-trip stressor. Four in ten said sleep and recovery advice would be valuable, while four in ten wanted blackout windows.
WHO notes that jet lag and sleep deprivation can trigger seizures in people with epilepsy, provoke migraine attacks, and cause more behavioral symptoms in people living with dementia. This makes sleep planning relevant to individual medical needs, not merely comfort.
Workplace wellbeing and travel policy
BCD reported that mental health influenced travel arrangements for more than one-third of traveling employees, while physical health influenced arrangements for nearly half of business travelers. Physical and mental wellbeing support was extremely or very important to 85% of travelers in the survey, yet satisfaction with company support was about 10 points lower than its importance for both types of support.
In the same BCD research, a quarter of travelers wanted regular medical checks and a quarter wanted stress-management training. Desired stress-reduction measures included expat coaching for culture shock at 9%, mental-health counseling at 11%, and two other support options selected by 15% and 19% of respondents.
Travelers also identified concrete recovery measures. Nineteen percent wanted to limit trip or nights-away frequency, 9% wanted time off during a business trip, 39% wanted nutrition, sleep, and recovery advice, and 43% wanted time off after long trips. BCD’s travel-buyer survey found that 62% of buyers said their company provided wellbeing support; 14% planned to increase wellbeing budgets in 2022, 40% did not plan an increase, and 46% were unsure.
GBTA’s 2019 global traveler-sentiment research found 86% satisfaction with overall business travel experiences. Travel components were most closely correlated with satisfaction at 54%. Eighty-three percent considered workout facilities or walkable areas when booking hotels, 50% made time for exercise on roughly every trip, and 23% worked out more often on business trips than at home. The top wellness concerns were lack of sleep at 37%, general stress at 34%, and unhealthy eating at 33%.
The same research found demand for practical hotel features: in-room filtered drinking water was wanted by 77%, healthy food delivery by 73%, and air purifiers by 71%. These preferences complement, but do not replace, clinical travel advice.
Risk management and health documentation also shaped return-to-travel decisions. In GBTA’s March 2021 poll, 66% said digital health verification was a good policy; among supporters, 77% said it would help employees safely resume business travel and 64% called it a quick and easy way to document vaccination. Among opponents, 73% cited privacy concerns. After COVID-19 vaccination, 84% were very comfortable or comfortable traveling for business.
In an April 2021 GBTA poll, 74% of buyer and procurement respondents said employees were willing or very willing to travel for business, while 78% of member and stakeholder respondents considered government-issued digital health verification effective for resuming travel. Support for digital health verification was 63% among North American respondents and 72% among European respondents. In January 2022, 82% said employees were willing or very willing to travel, 68% expected to travel about as much or more than before the pandemic, and 79% thought the worst of Omicron was behind them. Company bookings were at pre-pandemic levels for 33% of respondents, compared with 42% reported by suppliers.
Finally, 72% of global travel buyers in a GBTA risk-management poll reported that their company had a risk-management plan. In a 2015 GBTA study, 83% of organizations said their travel programs had risk-management protocols. The CDC Yellow Book additionally says employers should cover required and recommended vaccinations, prophylactic medicines, and other health-protection measures, and that business travelers should use the free Department of State Smart Traveler Enrollment Program for alerts and emergency-contact support.